MedTrace Logo

Management of Dentinal Hypersensitivity Using Two Dentifrice Technologies

NCT07511530 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 57

Last updated 2026-04-14

No results posted yet for this study

Summary

This study evaluates the effectiveness of Scigates foam mouth sanitizer 2 in 1 toothpaste and mouthwash in reducing tooth sensitivity and improving tooth whitening compared to Lacalut® White \& Repair toothpaste. Participants will be randomly assigned to either the Scigates group or the Lacalut control group and will use the assigned product three times daily for 8 weeks. Tooth sensitivity and dental staining will be assessed at multiple time points using standardized clinical scales. Safety will also be monitored throughout the study.

Conditions

  • Dentin Hypersensitivity
  • Tooth Discoloration

Interventions

DRUG

Scigates Foam Mouth Sanitizer 2 in 1 Toothpaste and Mouthwash

Participants will use Scigates foam mouth sanitizer 2 in 1 toothpaste and mouthwash three times daily for 8 weeks by applying the product directly to the toothbrush and brushing for 2-3 minutes according to standardized instructions.

DRUG

Lacalut White and Repair Toothpaste

Participants will use Lacalut® White and Repair toothpaste three times daily for 8 weeks by applying the product directly to the toothbrush and brushing for 2-3 minutes according to standardized instructions.

Sponsors & Collaborators

  • Dr. Raed Alkhatib Dental Center

    collaborator UNKNOWN

  • The Jordan Center for Pharmaceutical Research (JCPR)

    collaborator UNKNOWN

  • Prof. Mayyas Al-Remawi

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-08-18
Primary Completion
2025-08-31
Completion
2025-08-31

Countries

  • Jordan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07511530 on ClinicalTrials.gov